| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7689e9aa4e22ebbe003ff5f0db439d9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b840490ce4e7830aa852a942094b9df0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2021-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85f2a6506b641b118701d3f416b69426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab97cd14e92edeedb24eae5219e93334
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f9a86bc37b052414d8584613cc2aa98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68c56c72991474b77d568ea58796d426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2db4402fbf2a4e51b29dc3315f967a57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13f3b9b6cb67a16a52d261dc93418678
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_724ff797b0dc714433a1ccd7ff420421 |
| publicationDate |
2021-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021193601-A1 |
| titleOfInvention |
Method for evaluating expression and function of megalin in human living tissue |
| abstract |
The present invention is a method for evaluating megalin expression level or megalin ligand reabsorption capability of megalin, the method including a step in which: 1) when the megalin concentration in urine or cerebral spinal fluid derived from a test subject decreases, it is evaluated that megalin expression is suppressed in the test subject and/or the megalin ligand reabsorption capability of megalin has been declined; and 2) when the megalin concentration in urine or cerebral spinal fluid derived from a test subject increases, it is evaluated that megalin expression is promoted in the test subject and/or the megalin ligand reabsorption capability of megalin has been increased. |
| priorityDate |
2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |